Logo
Oladoctor – online healthcare marketplace in Spain

Medicamentos de Biosimilar Collaborations Ireland Limited en Spain

O
OGIVRI 150 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
Dosage form:  INJECTABLE PERFUSION, 150 mg
Active substance:  trastuzumab
Manufacturer:  Biosimilar Collaborations Ireland Limited
Prescription required
OGIVRI 420 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
Dosage form:  INJECTABLE PERFUSION, 420 mg
Active substance:  trastuzumab
Manufacturer:  Biosimilar Collaborations Ireland Limited
Prescription required
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.
Follow us on social media